Genetic and Epigenetic Alterations in Bladder Cancer
Hong-Tao Li, Christopher E. Duymich, Daniel J. Weisenberger, Gangning Liang
Int Neurourol J. 2016;20(Suppl 2):S84-94.   Published online 2016 Nov 22
DOI: https://doi.org/10.5213/inj.1632752.376
Citations to this article as recorded by
  Crossref logo
Knockdown of lncRNA SNHG7 inhibited cell proliferation and migration in bladder cancer through activating Wnt/β-catenin pathway
Yi Chen, Ya Peng, Zhipeng Xu, Bo Ge, Xuebao Xiang, Tianyu Zhang, Li Gao, Hailin Shi, Chuang Wang, Jiefu Huang
Pathology - Research and Practice.2019; 215(2): 302.     CrossRef
Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF‐κB‐modulated tumor progression in bladder cancer in vitro and in vivo
Chih‐Hung Chiang, Jing‐Gung Chung, Fei‐Ting Hsu
Environmental Toxicology.2019; 34(6): 679.     CrossRef
Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine
Jan Gleichenhagen, Christian Arndt, Swaantje Casjens, Carmen Meinig, Holger Gerullis, Irina Raiko, Thomas Brüning, Thorsten Ecke, Georg Johnen
International Journal of Molecular Sciences.2018; 19(1): 226.     CrossRef
Role of Non-Coding RNAs in the Etiology of Bladder Cancer
Caterina Gulìa, Stefano Baldassarra, Fabrizio Signore, Giuliano Rigon, Valerio Pizzuti, Marco Gaffi, Vito Briganti, Alessandro Porrello, Roberto Piergentili
Genes.2017; 8(11): 339.     CrossRef
Differential expression of FGFRs signaling pathway components in bladder cancer: A step toward personalized medicine
Z Ousati Ashtiani, J Tavakkoly-Bazzaz, SA Salami, MR Pourmand, F Mansouri, R Mashahdi, G Pourmand
Balkan Journal of Medical Genetics.2017; 20(2): 75.     CrossRef
Are We Ready to Use the Omics Strategies for Precision Medicine?
Jayoung Kim
International Neurourology Journal.2016; 20(Suppl 2): S65.     CrossRef